Objectives

The main objectives of this group are:

• To provide implementers of the SNOMED CT drug extension model with a forum through which they can share their real world experiences, challenges and questions, with other stakeholders and SNOMED International.
• To provide SNOMED International with a forum through which we can better understand how to assist implementers of the SNOMED CT drug extension model.

Please note that "implementing" the SNOMED CT drug extension model may involve any of the following activities:

• Creating a national SNOMED CT drug extension to support clinical systems;
• Mapping an existing national drug model to SNOMED International's drug model to support interoperability and cross-border data sharing;
• Integrating a SNOMED CT drug extension with other drug standards, such as ISO's Identification of Medicinal Products (IDMP) standard;
• Utilising the SNOMED CT drug model to implement clinical decision support (CDS); or
• Developing clinical implementations that use a drug dictionary based on the SNOMED CT drug extension model..

Goals

The primary goals of this group are:

• To enable the successful implementation of national SNOMED CT drug extensions, that meet the requirements of both national use and cross-border data sharing.
• To enable the successful interoperability between national SNOMED CT drug extensions and other medicinal product standards required for national or cross-border data sharing.

Membership

This group is open to any stakeholder from the SNOMED CT community who is either actively using, planning to use, or interested in using the SNOMED CT drug extension model.

The group will initially be co-chaired by Linda Bird (SNOMED International) and Julie James (UK). All participants will be encouraged to participate and contribute to the agenda and discussions.

Meetings

Meetings will typically include the opportunity for one or more participants to explain the plans and objectives of a relevant project that they are directly involved in, and then to start a discussion about any questions or challenges they are facing as part of this project. Similar discussions incorporating lessons learnt from established projects are also anticipated.

DEUSG meetings will use this zoom link (passcode: 520524), and be held every two weeks.

The first meeting was held on Thursday 29th October 2020 at 11:00 UTC. 

The next meeting will be held on Thursday 10th December 2020 at 11:00 UTC.

For a full list of meetings, please visit DEUSG Meetings.

Relevant Documentation

The following documents* may be relevant to some or all participants:

1. SNOMED CT Model Specifications (see Reference Documentation - Medicinal Product Model)
   • National Drug Extension Model - SNOMED CT Drug Model for supporting National Extensions v1.0.pdf
   • International Drug Model - SNOMED CT Medicinal Product Model Specification v3.0
2. SNOMED CT Editorial Guidelines (see Reference Documentation - Medicinal Product Model)
   • Medicinal Product Hierarchy - Editorial Guidelines (v3.0)
   • Pharmaceutical Dose Form Hierarchy - Editorial Guidelines (v1.0)
   • Roles - Editorial Guidelines (v1.0)
     • List of roles that have been remodeled
3. SNOMED CT Drugs Project
   • Drugs Project Confluence Space
4. Other Relevant Standards
   • ISO TC215 WG6 - Identification of Medicinal Products (IDMP)
   • UNICOM Project - https://unicom-project.eu/ 

* Please note that some of the links above require a SNOMED International Confluence account to access. To apply for a Confluence account please fill in the application form here. Or alternatively, you can access the specifications and guidelines via the attachments below.